The amfAR is inviting proposals to support mechanistic, preclinical and translational research aimed at restoring, redirecting, or amplifying anti-tumor immunity by targeting dysfunctional, suppressive, senescent or otherwise ineffective immune states in cancer. The funding opportunity supports research on immune reprogramming strategies, including restoring dysfunctional immune cells, modifying suppressive tumor environments, enhancing anti-tumor immune responses, developing
Access Restricted: Members-Only Content. We're sorry, but this content is available exclusively to our subscribed members: